SLC11A1 and bacterial infectious disease: Taken together, this study provides a mechanism underlying the control of intracellular bacterial infection by ERRγ inverse agonist, GSK5182, although further studies would elucidate the role of Nramp1 in conjunction with FPN in intracellular bacterial infection.